|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
silmitasertib results in decreased phosphorylation of AKT1 protein [mirdametinib co-treated with silmitasertib] results in decreased phosphorylation of AKT1 protein; silmitasertib inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; silmitasertib inhibits the reaction [Formaldehyde affects the phosphorylation of AKT1 protein] |
CTD |
PMID:21174434 PMID:25798061 PMID:36534342 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression |
ISO |
silmitasertib results in decreased expression of BAX protein |
CTD |
PMID:25798061 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
silmitasertib results in decreased expression of BCL2L1 protein |
CTD |
PMID:25798061 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases phosphorylation multiple interactions |
ISO |
silmitasertib results in decreased phosphorylation of CDKN1A protein silmitasertib affects the expression of and results in decreased phosphorylation of CDKN1A protein |
CTD |
PMID:21174434 PMID:25798061 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Csnk2a1 |
casein kinase 2 alpha 1 |
multiple interactions |
ISO |
silmitasertib affects the reaction [Formaldehyde affects the phosphorylation of CSNK2A1 protein]; silmitasertib inhibits the reaction [Adenosine Triphosphate binds to [CSNK2A1 protein binds to CSNK2A1 protein binds to CSNK2B protein binds to CSNK2B protein]]; silmitasertib results in decreased activity of [CSNK2A1 protein binds to CSNK2A1 protein binds to CSNK2B protein binds to CSNK2B protein] |
CTD |
PMID:21174434 PMID:36534342 |
|
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
|
|
G |
Csnk2b |
casein kinase 2 beta |
multiple interactions |
ISO |
silmitasertib inhibits the reaction [Adenosine Triphosphate binds to [CSNK2A1 protein binds to CSNK2A1 protein binds to CSNK2B protein binds to CSNK2B protein]]; silmitasertib results in decreased activity of [CSNK2A1 protein binds to CSNK2A1 protein binds to CSNK2B protein binds to CSNK2B protein] |
CTD |
PMID:21174434 |
|
NCBI chr20:3,700,363...3,705,331
Ensembl chr20:3,698,733...3,707,133
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
silmitasertib inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; silmitasertib inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; silmitasertib inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:36534342 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO |
[mirdametinib co-treated with silmitasertib] results in decreased expression of FOSL1 protein silmitasertib results in increased expression of FOSL1 protein |
CTD |
PMID:25798061 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Hdac3 |
histone deacetylase 3 |
multiple interactions |
ISO |
silmitasertib inhibits the reaction [[manganese chloride results in increased abundance of Manganese] promotes the reaction [YY1 protein binds to HDAC3 protein]] |
CTD |
PMID:34800614 |
|
NCBI chr18:29,770,637...29,789,850
Ensembl chr18:29,770,636...29,793,856
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
silmitasertib results in increased expression of JUNB protein |
CTD |
PMID:25798061 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation affects phosphorylation |
ISO |
[mirdametinib co-treated with silmitasertib] results in decreased phosphorylation of MAPK1 protein; silmitasertib affects the reaction [Formaldehyde affects the phosphorylation of MAPK1 protein]; silmitasertib inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein] silmitasertib results in increased phosphorylation of MAPK1 protein silmitasertib affects the phosphorylation of MAPK1 protein |
CTD |
PMID:25798061 PMID:36534342 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation affects phosphorylation multiple interactions |
ISO |
silmitasertib results in increased phosphorylation of MAPK3 protein silmitasertib affects the phosphorylation of MAPK3 protein [mirdametinib co-treated with silmitasertib] results in decreased phosphorylation of MAPK3 protein; silmitasertib affects the reaction [Formaldehyde affects the phosphorylation of MAPK3 protein]; silmitasertib inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:25798061 PMID:36534342 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression |
ISO |
silmitasertib results in increased expression of MKI67 protein |
CTD |
PMID:25798061 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
decreases phosphorylation |
ISO |
silmitasertib results in decreased phosphorylation of RELA protein |
CTD |
PMID:25798061 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rps6 |
ribosomal protein S6 |
decreases phosphorylation |
ISO |
silmitasertib results in decreased phosphorylation of RPS6 protein |
CTD |
PMID:25798061 |
|
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
|
|
G |
Slc1a2 |
solute carrier family 1 member 2 |
multiple interactions |
ISO |
silmitasertib inhibits the reaction [[manganese chloride results in increased abundance of Manganese] promotes the reaction [YY1 protein binds to SLC1A2 promoter]]; silmitasertib inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC1A2 protein] |
CTD |
PMID:34800614 |
|
NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498
|
|
G |
Tp53 |
tumor protein p53 |
decreases expression affects expression |
ISO |
silmitasertib results in decreased expression of TP53 protein silmitasertib affects the expression of TP53 protein |
CTD |
PMID:25798061 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Yy1 |
YY1 transcription factor |
multiple interactions |
ISO |
silmitasertib inhibits the reaction [[manganese chloride results in increased abundance of Manganese] promotes the reaction [YY1 protein binds to HDAC3 protein]]; silmitasertib inhibits the reaction [[manganese chloride results in increased abundance of Manganese] promotes the reaction [YY1 protein binds to SLC1A2 promoter]]; silmitasertib inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased phosphorylation of and affects the localization of YY1 protein] |
CTD |
PMID:34800614 |
|
NCBI chr 6:127,706,739...127,736,499
Ensembl chr 6:127,707,596...127,732,747
|
|